Migraine neuroscience: from experimental models to target therapy

Research output: Contribution to journalReview articlepeer-review


Migraine sciences have witnessed tremendous advances in recent years. Pre-clinical and clinical experimental models have contributed significantly to provide useful insights into the brain structures that mediate migraine attacks. These models have contributed to elucidate the role of neurotransmission pathways and to identify the role of important molecules within the complex network involved in migraine pathogenesis. The contribution and efforts of several research groups from all over the world has ultimately lead to the generation of novel therapeutic approaches, specifically targeted for the prevention of migraine attacks, the monoclonal antibodies directed against calcitonin gene-related peptide or its receptor. These drugs have been validated in randomized placebo-controlled trials and are now ready to improve the lives of a large multitude of migraine sufferers. Others are in the pipeline and will soon be available.

Original languageEnglish
Pages (from-to)351-361
Number of pages11
JournalNeurol. Sci.
Volume41 (Suppl 2)
Publication statusPublished - Oct 25 2020


Dive into the research topics of 'Migraine neuroscience: from experimental models to target therapy'. Together they form a unique fingerprint.

Cite this